Skip to contentC
Collegium Pharmaceutical, Inc
C
COLLCollegium Pharmaceutical, Inc Q1 2019 · 10-Q
Revenue$74.52M$74.52M+16.9% vs Q1 2018 Net Income-$9.70M-$9.70MN/M vs Q1 2018 EPS Diluted-$0.29-$0.29N/M vs Q1 2018 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
Operating Cash Flow-$8,569,000N/M Free Cash Flowderived-$11,892,000N/M Margins · derivedGross margin34.0%
Operating margin-13.4%+7.3 pt vs Q1 2018
Net margin-13.0%+16.2 pt vs Q1 2018
ended Mar 31, 2019 · filed May 8, 2019 · 38 d after period end